Form 4: Inovio Pharmaceuticals, Inc. (INO), Benito Simon X, transaction 05/13/2021

Summary

Simon X. Benito, a Director of INOVIO PHARMACEUTICALS, INC. [ INO ], reports receiving on 05/13/2021, under the issuer's non-employee director compensation policy, Common Stock Options for 27,000 shares at $ 6.23 and 18,000 Restricted Stock Units, both to vest 100% on May 13, 2022. On 05/14/2021, 8,700 restricted stock units vested and were settled in Common Stock, and on 05/17/2021 3,045 shares were sold at $ 6.62 under a Rule 10b5-1 trading plan. Direct holdings after the sale are 57,305 shares. The form is signed /s/ Simon X. Benito, 05/17/2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * BENITO SIMON X (Last) (First) (Middle) 660 W. GERMANTOWN PIKE, SUITE 110 (Street) PLYMOUTH MEETING PA 19462 (City) (State) (Zip) | BENITO SIMON X | (Last) | (First) | (Middle) | 660 W. GERMANTOWN PIKE, SUITE 110 | PLYMOUTH MEETING | PA | 19462 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol INOVIO PHARMACEUTICALS, INC. [ INO ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) | X | Director | 10% Owner | Officer (give title below) | Other (specify below)
3. Date of Earliest Transaction
 (Month/Day/Year) 05/13/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 05/14/2021 | M | 8,700 | A | (1) | 60,350 | D
Common Stock | 05/17/2021 | S (2) | 3,045 | D | $ 6.62 | 57,305 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Common Stock Options | $ 6.23 | 05/13/2021 | A | 27,000 (3) | (4) | 05/13/2031 | Common Stock | 27,000 | $ 0 | 27,000 | D
Restricted Stock Unit | (5) | 05/13/2021 | A | 18,000 (3) | (5) | (5) | Common Stock | 18,000 | $ 0 | 18,000 | D
Restricted Stock Unit | (1) | 05/14/2021 | M | 8,700 | (1) | (1) | Common Stock | 8,700 | $ 0 | 0 | D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 14, 2021.
2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
3. This grant was made pursuant to the issuer's non-employee director compensation policy.
4. Options to vest 100% on May 13, 2022.
5. Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022.
Remarks:
/s/ Simon X. Benito | 05/17/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_INO_4_filed2021-05-17_0001055726-21-000044.xml

Size

19,536 bytes

SHA-256

5e02048c3dd59ddd3b36ad24e5fc79b15e2a5ba7749b2532845e72f5fe8f4e86

Our copy

SEC_INO_4_filed2021-05-17_0001055726-21-000044.xml

Original

www.sec.gov